ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $11,631 | +34.3% | 618 | +13.6% | 0.00% | – |
Q4 2022 | $8,660 | -3.8% | 544 | 0.0% | 0.00% | – |
Q3 2022 | $9,000 | +12.5% | 544 | 0.0% | 0.00% | – |
Q2 2022 | $8,000 | -38.5% | 544 | 0.0% | 0.00% | – |
Q1 2022 | $13,000 | 0.0% | 544 | 0.0% | 0.00% | – |
Q4 2021 | $13,000 | +44.4% | 544 | 0.0% | 0.00% | – |
Q3 2021 | $9,000 | -30.8% | 544 | 0.0% | 0.00% | – |
Q2 2021 | $13,000 | -7.1% | 544 | 0.0% | 0.00% | – |
Q1 2021 | $14,000 | -50.0% | 544 | +2.3% | 0.00% | – |
Q4 2020 | $28,000 | – | 532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |